Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
For proper mammalian brain development and functioning, the translation of many neuronal mRNAs needs to be repressed without neuronal activity stimulations. We have discovered that the expression of a subclass of neuronal proteins essential for neurodevelopment and neuron plasticity is co-regulated at the translational level by TDP-43 and the Fragile X Syndrome protein FMRP. Using molecular, cellular and imaging approaches, we show that these two RNA-binding proteins (RBP) co-repress the translation initiation of Rac1, Map1b and GluR1 mRNAs, and consequently the hippocampal spinogenesis. The co-repression occurs through binding of TDP-43 to mRNA(s) at specific UG/GU sequences and recruitment of the inhibitory CYFIP1-FMRP complex by its glycine-rich domain. This novel regulatory scenario could be utilized to silence a significant portion of around 160 common target mRNAs of the two RBPs. The study establishes a functional/physical partnership between FMRP and TDP-43 that mechanistically links several neurodevelopmental disorders and neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 3×
“Secondly, FMRP can inhibit translation at the elongation stage by directly interacting with the translating ribosomes [17].”
BackgroundA census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032 · cited 1×
“Aberrant expression and mutations in RBP genes affect various RNA processing steps and alter the target gene expression [25].”
BackgroundConverging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 2×
“, despite little being known about its associated mechanisms [4, 38, 42, 67].”
BackgroundLong pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 3×
“1 3 the translating polyribosomes [17, 33], equally distributed between the polysomes or monosomes and mRNPs [5, 9, 27], or mostly non-polysomal and associated with the translation initiation complexes [48, 71].”
BackgroundTDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · cited 4×
“Finally, and mostly observed in synaptosomes and activated neurons, FMRP is primarily non-polysomic in nature, gets fractionated with translation initiation complex and mRNPs, and inhibits the initiation of translation [37, 72].”
BackgroundInfluentialActivity-dependent neuronal signalling and autism spectrum disorder
Ebert, D. H., & Greenberg, M. E. (2013) · Nature · doi:10.1038/nature11860 · Cited by 666 · cited 1×
“For example, genetically and biologically, ~20 % of gene/RNA targets of FMRP overlap with genes associated with ASDs, whereas only up to 5 % of ASD patients carry any type of mutation at the FMR1 gene [2, 19].”
BackgroundGains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 2×
“On the other hand, gain-of-toxicity has also been suggested to contribute to the pathogenesis of ALS-TDP and FTLD-TDP [8, 41, 63].”
BackgroundDynamic visualization of local protein synthesis in hippocampal neurons
Aakalu, G., Smith, W. B., Nguyen, N., Jiang, C., & Schuman, E. M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00295-1 · Cited by 611
The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
Napoli, I., Mercaldo, V., Boyl, P. P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.031 · Cited by 609
A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins
Ishizuka, A., Siomi, M. C., & Siomi, H. (2002) · Genes & Development · doi:10.1101/gad.1022002 · Cited by 581 · cited 1×
“1 3 the translating polyribosomes [17, 33], equally distributed between the polysomes or monosomes and mRNPs [5, 9, 27], or mostly non-polysomal and associated with the translation initiation complexes [48, 71].”
BackgroundEvidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Santoro, M. R., Bray, S. M., & Warren, S. T. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132457 · Cited by 528 · cited 1×
“FMRP represses translation through three different pathways [12, 55].”
BackgroundThe translation of translational control by FMRP: therapeutic targets for FXS
Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491 · cited 1×
“Depletion of FMRP in diseased cells causes an increase in the translation of a number of proteins important for dendritic spine development [16, 59].”
BackgroundMuddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Osterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · cited 1×
“In an FXS mouse model, loss of FMRP causes an increased global level of protein synthesis [50], resulting in a high density of dendritic spines [10] as well as affecting the brain development and synaptic plasticity [59].”
BackgroundTranslational control in synaptic plasticity and cognitive dysfunction
Buffington, S. A., Huang, W., & Costa-Mattioli, M. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014100 · Cited by 348
Phosphorylation influences the translation state of FMRP-associated polyribosomes
Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327 · cited 1×
“In this case FMRP protein was found to be mostly co-sedimented with higher polysome fractions [11, 60].”
BackgroundFragile X mental retardation protein is associated with translating polyribosomes in neuronal cells
Stefani, G., Fraser, C. E., Darnell, J. C., & Darnell, R. B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2306-04.2004 · Cited by 274 · cited 2×
“In this case FMRP protein was found to be mostly co-sedimented with higher polysome fractions [11, 60].”
BackgroundTDP‐43, a neuro‐pathosignature factor, is essential for early mouse embryogenesis
Wu, L., Cheng, W., Hou, S., Yan, Y., Jiang, S., & Shen, C. ‐. J. (2010) · genesis · doi:10.1002/dvg.20584 · Cited by 256
Self-citationModeling fragile X syndrome in the Fmr1 knockout mouse
Kazdoba, T. M., Leach, P. T., Silverman, J. L., & Crawley, J. N. (2014) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2014.01024 · Cited by 241
A novel function for fragile X mental retardation protein in translational activation
Bechara, E. G., Didiot, M. C., Melko, M., Davidovic, L., Bensaid, M., Martin, P., Castets, M., Pognonec, P., Khandjian, E. W., Moine, H., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000016 · Cited by 206 · cited 1×
“1 3 the translating polyribosomes [17, 33], equally distributed between the polysomes or monosomes and mRNPs [5, 9, 27], or mostly non-polysomal and associated with the translation initiation complexes [48, 71].”
BackgroundKhandjian, E. W., Huot, M.-E., Tremblay, S., Davidovic, L., Mazroui, R., & Bardoni, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405398101 · Cited by 178 · cited 1×
“1 3 the translating polyribosomes [17, 33], equally distributed between the polysomes or monosomes and mRNPs [5, 9, 27], or mostly non-polysomal and associated with the translation initiation complexes [48, 71].”
BackgroundPlante, I., Davidovic, L., Ouellet, D. L., Gobeil, L.-A., Tremblay, S., Khandjian, E. W., & Provost, P. (2006) · BioMed Research International · doi:10.1155/jbb/2006/64347 · Cited by 119 · cited 1×
“, PSD-95, in neurons in an activity-dependent manner [51].”
BackgroundCYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome
Abekhoukh, S., & Bardoni, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00081 · Cited by 110 · cited 1×
“Moreover, based on genetic linkage and functional properties, CYFIP1/2 proteins are good causal candidates for autism, though a precise functional role remains to be identified [3].”
BackgroundRegulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders
De Rubeis, S., & Bagni, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9087-2 · Cited by 73 · cited 1×
“Impairment of this process, such as in FXS through silencing of the translational repressor FMRP, would lead to relief of translational repression of many mRNAs and development of neurological disorders [18, 59].”
Background
Cited by
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
Suk, T. R., & Rousseaux, M. W. C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00397-1 · Cited by 450
Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions
Nussbacher, J. K., Tabet, R., Yeo, G. W., & Lagier-Tourenne, C. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.014 · Cited by 272
Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome
Martinez, L. A., & Tejada-Simon, M. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0819-5 · Cited by 14
Martinez, L. A., & Tejada-Simon, M. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0666-4 · Cited by 13
Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
Peng, X., Wellard, N., Ghosh, A., Troakes, C., & Giese, K. P. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110849 · Cited by 6
Metadata
- Authors
- Majumder, P., Chu, J.-F., Chatterjee, B., Swamy, K. B. S., & Shen, C.-K. J.
- Venue
- Acta Neuropathologica
- Published
- 2016-08-12
- Volume
- 132
- Issue
- 5
- Pages
- 721-738
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2518422135
- Cited by
- 100
- References
- 27
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.